Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SANGUINE CORP. (SGNC) -- Ignore unavailable to you. Want to Upgrade?

To: Prospector who wrote (83)	6/8/1998 11:36:00 PM
From: chirodoc	Respond to of 5402

<<<<" The development of this product presently comprises its sole business operations. PHER-O2 is composed of perfluoro-decalin molecules (i.e., synthetic red blood cells), purified water and a proprietary, synthetic, fluorinated surfactant to hold the emulsion together. ...they key is from edgar: " and a proprietary, synthetic, fluorinated surfactant." .....the question is: does dr. d's binding agent have something that makes this stuff more compatible with blood? hey mr. p: how about calling up the guru and asking him about his "proprietary process." ..........this is gettin' interestin' ................still diggin' curtis